Oculis

ONL Therapeutics

This biopharmaceutical company develops neuroprotective peptide therapies to prevent retinal cell death and preserve vision for patients with retinal diseases and conditions.

Azura Ophthalmics

This biopharmaceutical company develops ophthalmic keratolytics to treat patients suffering from meibomian gland dysfunction and other ocular surface diseases.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Tavo Biotherapeutics

The company develops topical and injectable treatments for patients with glaucoma and retinal diseases.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Kedalion Therapeutics

This company develops electromechanical ocular delivery devices for patients with eye conditions requiring precise topical medication administration.